Mp42-11 excessive risks for developing renal failure after cytoreductive nephrectomy in the metastatic setting
Though radical cytoreductive nephrectomy has been shown to improve overall survival in patients with metastatic renal cell carcinoma, the impact this treatment has on renal function has not been adequately assessed. Radical nephrectomy in patients with localized cancer has been associated with risk of chronic kidney disease development. Using patients enrolled in ADAPT trial that received cytoreductive nephrectomy in the metastatic setting, we intend to study the effect of this procedure on overall renal function in patients without kidney disease.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Christopher Martin, Erik Mayer, Robert Uzzo, Brian Lane, Alexander Kutikov, Marc Smaldone, Jason Gee, Larry Karsh, Thomas Gardner, Viraj Master, Jeffrey Holzbeierlein, William Lowrance Tags: Kidney Cancer: Localized: Surgical Therapy IV Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chronic Kidney Disease | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Renal Failure | Study | Urology & Nephrology